Assessment of Fraction of Exhaled Nitric Oxide and Soluble Receptor for Advanced Glycation End Products Biomarkers for Jordanian Asthmatic Children

Ebaa M Alzayadneh,1 Suzan A Al Bdour,1 Eman R Elayeh,2 Mai M Ababneh,3 Ruqaya A Al-ani,3 Alia Shatanawi,4 Montaha Al-Iede,3 Enas Al-Zayadneh3 1Department of Physiology and Biochemistry, School of Medicine, The University of Jordan, Amman, Jordan; 2Department of Biopharmaceutics and Clinical Pharmacy...

Full description

Bibliographic Details
Main Authors: Alzayadneh EM, Al Bdour SA, Elayeh ER, Ababneh MM, Al-ani RA, Shatanawi A, Al-Iede M, Al-Zayadneh E
Format: Article
Language:English
Published: Dove Medical Press 2023-08-01
Series:Journal of Asthma and Allergy
Subjects:
Online Access:https://www.dovepress.com/assessment-of-fraction-of-exhaled-nitric-oxide-and-soluble-receptor-fo-peer-reviewed-fulltext-article-JAA
_version_ 1797755252518158336
author Alzayadneh EM
Al Bdour SA
Elayeh ER
Ababneh MM
Al-ani RA
Shatanawi A
Al-Iede M
Al-Zayadneh E
author_facet Alzayadneh EM
Al Bdour SA
Elayeh ER
Ababneh MM
Al-ani RA
Shatanawi A
Al-Iede M
Al-Zayadneh E
author_sort Alzayadneh EM
collection DOAJ
description Ebaa M Alzayadneh,1 Suzan A Al Bdour,1 Eman R Elayeh,2 Mai M Ababneh,3 Ruqaya A Al-ani,3 Alia Shatanawi,4 Montaha Al-Iede,3 Enas Al-Zayadneh3 1Department of Physiology and Biochemistry, School of Medicine, The University of Jordan, Amman, Jordan; 2Department of Biopharmaceutics and Clinical Pharmacy, School of Pharmacy, The University of Jordan, Amman, Jordan; 3Department of Pediatrics, School of Medicine, The University of Jordan, Amman, Jordan; 4Department of Pharmacology, School of Medicine, The University of Jordan, Amman, JordanCorrespondence: Ebaa M Alzayadneh, Tel +962796972717, Fax +96265300820, Email e.zayadneh@ju.edu.joPurpose: Fraction of exhaled nitric oxide (FeNO) and soluble advanced glycation end-product receptor (sRAGE) are proposed as biomarkers of asthma, therefore we sought to assess their use in asthmatic children of Jordan.Patients and Methods: We conducted a case-control study at The University of Jordan Hospital. A total of 141 asthmatic children followed by respiratory pediatricians and 118 healthy children aged 4– 18 years were recruited. FeNO was measured by NObreath device and serum sRAGE by ELISA that detect endogenously soluble isoform (esRAGE) and total soluble RAGE (sRAGE).Results: sRAGE in asthmatic was half of the control (p < 0.001). In addition, ratio of esRAGE/sRAGE was two-fold higher in asthmatic (p = < 0.001). Neither FeNO nor esRAGE levels were significantly different between groups. FeNO and asthma control test (ACT) score were negatively correlated corrected for age and body mass index (BMI), (r = − 0.180, p= 0.034). For the uncontrolled asthma group, esRAGE/sRAGE negatively correlated with ACT score (r = − .329, p = 0.038). Receiver operating curve (ROC) analysis revealed significant predictive value (PV) for sRAGE and esRAGE/sRAGE in asthma detection with area under the curve (AUC) of (0.751 ± 0.031) and (0.711± .033), consequently. However, no biomarker had a significant PV for lack of control.Conclusion: The current study supports utilizing sRAGE as a marker for asthma and present a potential therapeutic target. However, our results indicate that both FeNO and sRAGE have a limited role in the management of asthmatic children or assessment of asthma control.Keywords: childhood asthma, allergy, inflammation, asthma control test
first_indexed 2024-03-12T17:45:09Z
format Article
id doaj.art-f23cf30f6e3344f693e952e0f6010563
institution Directory Open Access Journal
issn 1178-6965
language English
last_indexed 2024-03-12T17:45:09Z
publishDate 2023-08-01
publisher Dove Medical Press
record_format Article
series Journal of Asthma and Allergy
spelling doaj.art-f23cf30f6e3344f693e952e0f60105632023-08-03T19:02:12ZengDove Medical PressJournal of Asthma and Allergy1178-69652023-08-01Volume 1679381185668Assessment of Fraction of Exhaled Nitric Oxide and Soluble Receptor for Advanced Glycation End Products Biomarkers for Jordanian Asthmatic ChildrenAlzayadneh EMAl Bdour SAElayeh ERAbabneh MMAl-ani RAShatanawi AAl-Iede MAl-Zayadneh EEbaa M Alzayadneh,1 Suzan A Al Bdour,1 Eman R Elayeh,2 Mai M Ababneh,3 Ruqaya A Al-ani,3 Alia Shatanawi,4 Montaha Al-Iede,3 Enas Al-Zayadneh3 1Department of Physiology and Biochemistry, School of Medicine, The University of Jordan, Amman, Jordan; 2Department of Biopharmaceutics and Clinical Pharmacy, School of Pharmacy, The University of Jordan, Amman, Jordan; 3Department of Pediatrics, School of Medicine, The University of Jordan, Amman, Jordan; 4Department of Pharmacology, School of Medicine, The University of Jordan, Amman, JordanCorrespondence: Ebaa M Alzayadneh, Tel +962796972717, Fax +96265300820, Email e.zayadneh@ju.edu.joPurpose: Fraction of exhaled nitric oxide (FeNO) and soluble advanced glycation end-product receptor (sRAGE) are proposed as biomarkers of asthma, therefore we sought to assess their use in asthmatic children of Jordan.Patients and Methods: We conducted a case-control study at The University of Jordan Hospital. A total of 141 asthmatic children followed by respiratory pediatricians and 118 healthy children aged 4– 18 years were recruited. FeNO was measured by NObreath device and serum sRAGE by ELISA that detect endogenously soluble isoform (esRAGE) and total soluble RAGE (sRAGE).Results: sRAGE in asthmatic was half of the control (p < 0.001). In addition, ratio of esRAGE/sRAGE was two-fold higher in asthmatic (p = < 0.001). Neither FeNO nor esRAGE levels were significantly different between groups. FeNO and asthma control test (ACT) score were negatively correlated corrected for age and body mass index (BMI), (r = − 0.180, p= 0.034). For the uncontrolled asthma group, esRAGE/sRAGE negatively correlated with ACT score (r = − .329, p = 0.038). Receiver operating curve (ROC) analysis revealed significant predictive value (PV) for sRAGE and esRAGE/sRAGE in asthma detection with area under the curve (AUC) of (0.751 ± 0.031) and (0.711± .033), consequently. However, no biomarker had a significant PV for lack of control.Conclusion: The current study supports utilizing sRAGE as a marker for asthma and present a potential therapeutic target. However, our results indicate that both FeNO and sRAGE have a limited role in the management of asthmatic children or assessment of asthma control.Keywords: childhood asthma, allergy, inflammation, asthma control testhttps://www.dovepress.com/assessment-of-fraction-of-exhaled-nitric-oxide-and-soluble-receptor-fo-peer-reviewed-fulltext-article-JAAchildhood asthmaallergyinflammationasthma control test
spellingShingle Alzayadneh EM
Al Bdour SA
Elayeh ER
Ababneh MM
Al-ani RA
Shatanawi A
Al-Iede M
Al-Zayadneh E
Assessment of Fraction of Exhaled Nitric Oxide and Soluble Receptor for Advanced Glycation End Products Biomarkers for Jordanian Asthmatic Children
Journal of Asthma and Allergy
childhood asthma
allergy
inflammation
asthma control test
title Assessment of Fraction of Exhaled Nitric Oxide and Soluble Receptor for Advanced Glycation End Products Biomarkers for Jordanian Asthmatic Children
title_full Assessment of Fraction of Exhaled Nitric Oxide and Soluble Receptor for Advanced Glycation End Products Biomarkers for Jordanian Asthmatic Children
title_fullStr Assessment of Fraction of Exhaled Nitric Oxide and Soluble Receptor for Advanced Glycation End Products Biomarkers for Jordanian Asthmatic Children
title_full_unstemmed Assessment of Fraction of Exhaled Nitric Oxide and Soluble Receptor for Advanced Glycation End Products Biomarkers for Jordanian Asthmatic Children
title_short Assessment of Fraction of Exhaled Nitric Oxide and Soluble Receptor for Advanced Glycation End Products Biomarkers for Jordanian Asthmatic Children
title_sort assessment of fraction of exhaled nitric oxide and soluble receptor for advanced glycation end products biomarkers for jordanian asthmatic children
topic childhood asthma
allergy
inflammation
asthma control test
url https://www.dovepress.com/assessment-of-fraction-of-exhaled-nitric-oxide-and-soluble-receptor-fo-peer-reviewed-fulltext-article-JAA
work_keys_str_mv AT alzayadnehem assessmentoffractionofexhalednitricoxideandsolublereceptorforadvancedglycationendproductsbiomarkersforjordanianasthmaticchildren
AT albdoursa assessmentoffractionofexhalednitricoxideandsolublereceptorforadvancedglycationendproductsbiomarkersforjordanianasthmaticchildren
AT elayeher assessmentoffractionofexhalednitricoxideandsolublereceptorforadvancedglycationendproductsbiomarkersforjordanianasthmaticchildren
AT ababnehmm assessmentoffractionofexhalednitricoxideandsolublereceptorforadvancedglycationendproductsbiomarkersforjordanianasthmaticchildren
AT alanira assessmentoffractionofexhalednitricoxideandsolublereceptorforadvancedglycationendproductsbiomarkersforjordanianasthmaticchildren
AT shatanawia assessmentoffractionofexhalednitricoxideandsolublereceptorforadvancedglycationendproductsbiomarkersforjordanianasthmaticchildren
AT aliedem assessmentoffractionofexhalednitricoxideandsolublereceptorforadvancedglycationendproductsbiomarkersforjordanianasthmaticchildren
AT alzayadnehe assessmentoffractionofexhalednitricoxideandsolublereceptorforadvancedglycationendproductsbiomarkersforjordanianasthmaticchildren